Clinical Trial

Health Properties of Pecan Nut Consumption

Recruiting
View on ClinicalTrials.gov →
Summary
The main goal of this clinical study is to see if consuming pecan nuts will result in improvements in overall body metabolism such as in blood lipids, markers of inflammation, blood pressure, cognitive performance and changes in bacteria living in the gut in adults 45 to 75 years of age. Participants will take part in two 3-month intervention periods, separated by 4-6 weeks, in random order ( a total of approximately 7 months). During one intervention period, they will include pecan nuts in their diet each day, while during the other intervention period they will avoid pecans in their diet. There will be an initial screening visit to evaluate eligibility and four study visits to the clinic. Participants will be asked to complete some questionnaires about their diet, physical and cognitive health, and provide blood and stool samples, and have their blood pressure measured.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-09.
Trial Details
NCT Number NCT07227259
Lead Sponsor University of California, Davis
Conditions Healthy Adults
Enrollment 40 participants
Start Date 2025-11-15
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-02-24